Last reviewed · How we verify
NCT07285343
Comparison Between Lip Repositioning and Muscle Traction Technique in Treatment of Gummy Smile
NA trial testing lip repositioning in Gummy Smile Due to Hypermobile Upper Lip in 20 participants. Completed in 1 March 2025.
1 January 2025
Quick facts
| Lead sponsor | Suez Canal University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 March 2023 |
| Primary completion | 1 January 2025 |
| Estimated completion | 1 March 2025 |
| Sites | 2 locations across Egypt |
Drugs / interventions tested
- lip repositioning
- Containment of the elevator muscle of the upper lip and wing of nose (EMULWN) technique
Conditions studied
- Gummy Smile Due to Hypermobile Upper Lip — all drugs for Gummy Smile Due to Hypermobile Upper Lip →
- Excessive Gingival Display — all drugs for Excessive Gingival Display →
Sponsor
Suez Canal University
Who can join
Adults 18 to 38, any sex, with Gummy Smile Due to Hypermobile Upper Lip or Excessive Gingival Display. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to compare and evaluate the effectiveness of conventional and modified lip repositioning for the treatment of gummy smile. The main question it aims to answer: Which of these treatment modalities (conventional lip repositioning and containment of the elevator muscle of the upper lip and wing of nose (EMULWN)) has the most durable and least relapse in the treatment of gummy smile?" Researchers will compare: 1. The primary outcome was the decrease in excessive gingival display by measuring smile line (gingival display) and smile index before and after treatment modalities. 2. The The secondary outcome was to measure the durability and possibility of relapse over 6 months after treatment with high patient satisfaction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07285343
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Suez Canal University trials
Trials by the same sponsor.
- NCT07263893 — Inter Flex Three Dimensional Plate in Management of Mandibular Fracture RCT · NA · recruiting
- NCT07280533 — Accuracy of Virtual Surgical Planning Versus Traditional Technique in Zygomaticomaxillary Fracture Reduction · NA · not yet recruiting
- NCT07291791 — tDCS for Pain Modulation in Knee Osteoarthritis · NA · active not recruiting
- NCT07262086 — Clinical Evaluation of Wear Resistance and Bioactivity of Self Cured Bioactive Resin Composite · NA · enrolling by invitation
- NCT07125846 — Efficacy of Bioactive Glass vs. Xenograft in Maxillary Sinus Augmentation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07285343 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Suez Canal University
- Last refreshed: 16 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07285343.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing